{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T11:32:39Z","timestamp":1790854359267,"version":"4.1.0"},"reference-count":94,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,11]]},"DOI":"10.1097\/mcp.0b013e3283121cdc","type":"journal-article","created":{"date-parts":[[2008,9,22]],"date-time":"2008-09-22T07:08:32Z","timestamp":1222067312000},"page":"559-566","source":"Crossref","is-referenced-by-count":105,"title":["Update on gene modifiers in cystic fibrosis"],"prefix":"10.1097","volume":"14","author":[{"given":"Joseph M","family":"Collaco","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Garry R","family":"Cutting","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-10-20210206","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1126\/science.2475911","article-title":"Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA","volume":"245","author":"Riordan","year":"1989","journal-title":"Science"},{"key":"R2-10-20210206","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1126\/science.2570460","article-title":"Identification of the cystic fibrosis gene: genetic analysis","volume":"245","author":"Kerem","year":"1989","journal-title":"Science"},{"key":"R3-10-20210206","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/1099-0496(200101)31:1<1::AID-PPUL1000>3.0.CO;2-T","article-title":"European Epidemiologic Registry of Cystic Fibrosis (ERCF): comparison of major disease manifestations between patients with different classes of mutations","volume":"31","author":"Koch","year":"2001","journal-title":"Pediatr Pulmonol"},{"key":"R4-10-20210206","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1056\/NEJM199011293232203","article-title":"The relation between genotype and phenotype in cystic fibrosis \u2013 analysis of the most common mutation (deltaF508)","volume":"323","author":"Kerem","year":"1990","journal-title":"N Engl J Med"},{"key":"R5-10-20210206","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1056\/NEJM199310283291804","article-title":"Correlation between genotype and phenotype in cystic fibrosis.","volume":"329","year":"1993","journal-title":"N Engl J Med"},{"key":"R6-10-20210206","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1375\/136905200320565256","article-title":"Categories of deltaF508 homozygous cystic fibrosis twin and sibling pairs with distinct phenotypic characteristics","volume":"3","author":"Mekus","year":"2000","journal-title":"Twin Res"},{"key":"R7-10-20210206","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1164\/rccm.200608-1164OC","article-title":"Heritability of lung disease severity in cystic fibrosis","volume":"175","author":"Vanscoy","year":"2007","journal-title":"Am J Respir Crit Care Med"},{"key":"R8-10-20210206","first-page":"265","article-title":"TCF7L2, A risk gene for type 2 diabetes, is associated with cystic fibrosis-related diabetes","volume":"30","author":"Blackman","year":"2007","journal-title":"Pediatr Pulmonol Suppl"},{"key":"R9-10-20210206","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1053\/j.gastro.2006.07.016","article-title":"Relative contribution of genetic and nongenetic modifiers to intestinal obstruction in cystic fibrosis","volume":"131","author":"Blackman","year":"2006","journal-title":"Gastroenterology"},{"key":"R10-10-20210206","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1007\/s00439-007-0337-z","article-title":"Genetic polymorphisms in transforming growth factor beta-1 (TGFB1) and childhood asthma and atopy","volume":"121","author":"Li","year":"2007","journal-title":"Hum Genet"},{"key":"R11-10-20210206","first-page":"714","article-title":"Transforming growth factor-beta1 gene polymorphisms associated with chronic obstructive pulmonary disease in Chinese population","volume":"26","author":"Su","year":"2005","journal-title":"Acta Pharmacol Sin"},{"key":"R12-10-20210206","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1136\/thorax.2003.005769","article-title":"Transforming growth factor-beta1 genotype and susceptibility to chronic obstructive pulmonary disease","volume":"59","author":"Wu","year":"2004","journal-title":"Thorax"},{"key":"R13-10-20210206","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.jaci.2005.08.049","article-title":"Analysis of TGF-beta(1) gene polymorphisms in Hong Kong Chinese patients with asthma","volume":"117","author":"Mak","year":"2006","journal-title":"J Allergy Clin Immunol"},{"key":"R14-10-20210206","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1093\/hmg\/ddh171","article-title":"The transforming growth factor-beta1 (TGFB1) gene is associated with chronic obstructive pulmonary disease (COPD)","volume":"13","author":"Celedon","year":"2004","journal-title":"Hum Mol Genet"},{"key":"R15-10-20210206","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1007\/s00439-001-0617-y","article-title":"TGFbeta1 allele association with asthma severity","volume":"109","author":"Pulleyn","year":"2001","journal-title":"Hum Genet"},{"key":"R16-10-20210206","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1164\/rccm.200307-973OC","article-title":"Transforming growth factor-beta1 promoter polymorphism C-509T is associated with asthma","volume":"169","author":"Silverman","year":"2004","journal-title":"Am J Respir Crit Care Med"},{"key":"R17-10-20210206","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1038\/79216","article-title":"The common PPARgamma Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes","volume":"26","author":"Altshuler","year":"2000","journal-title":"Nat Genet"},{"key":"R18-10-20210206","first-page":"226","article-title":"Analysis of gene candidates for cystic fibrosis modifier 1 (CFM1) associated with meconium ileus in cystic fibrosis patients","volume":"24","author":"Zielenski","year":"2002","journal-title":"Pediatr Pulmonol Suppl"},{"key":"R19-10-20210206","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1164\/rccm.200204-364OC","article-title":"End-organ dysfunction in cystic fibrosis: association with angiotensin I converting enzyme and cytokine gene polymorphisms","volume":"167","author":"Arkwright","year":"2003","journal-title":"Am J Respir Crit Care Med"},{"key":"R20-10-20210206","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1056\/NEJMoa051469","article-title":"Genetic modifiers of lung disease in cystic fibrosis","volume":"353","author":"Drumm","year":"2005","journal-title":"N Engl J Med"},{"key":"R21-10-20210206","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1097\/00008571-200207000-00002","article-title":"Beta2 adrenoceptor gene polymorphisms in cystic fibrosis lung disease","volume":"12","author":"Buscher","year":"2002","journal-title":"Pharmacogenetics"},{"key":"R22-10-20210206","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1002\/ppul.20210","article-title":"Beta 2 adrenergic receptor polymorphisms in cystic fibrosis","volume":"39","author":"Hart","year":"2005","journal-title":"Pediatr Pulmonol"},{"key":"R23-10-20210206","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1097\/FPC.0b013e3280119349","article-title":"Beta-2-adrenergic receptor polymorphisms in cystic fibrosis","volume":"17","author":"Steagall","year":"2007","journal-title":"Pharmacogenet Genomics"},{"key":"R24-10-20210206","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1038\/sj.ejhg.5200726","article-title":"ATB(0)\/SLC1A5 gene. Fine localisation and exclusion of association with the intestinal phenotype of cystic fibrosis","volume":"9","author":"Larriba","year":"2001","journal-title":"Eur J Hum Genet"},{"key":"R25-10-20210206","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.jcf.2005.09.011","article-title":"Calpain 10 and development of diabetes mellitus in cystic fibrosis","volume":"5","author":"Derbel","year":"2006","journal-title":"J Cyst Fibros"},{"key":"R26-10-20210206","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/1471-2350-5-26","article-title":"CLC-2 single nucleotide polymorphisms (SNPs) as potential modifiers of cystic fibrosis disease severity","volume":"5","author":"Blaisdell","year":"2004","journal-title":"BMC Med Genet"},{"key":"R27-10-20210206","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1477-5751-4-9","article-title":"Beta-defensin genomic copy number is not a modifier locus for cystic fibrosis","volume":"4","author":"Hollox","year":"2005","journal-title":"J Negat Results Biomed"},{"key":"R28-10-20210206","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/s00439-006-0140-2","article-title":"The TNFalpha receptor TNFRSF1A and genes encoding the amiloride-sensitive sodium channel ENaC as modulators in cystic fibrosis 1","volume":"119","author":"Stanke","year":"2006","journal-title":"Hum Genet"},{"key":"R29-10-20210206","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1038\/sj.ejhg.5201285","article-title":"Fcgamma receptor IIA genotype and susceptibility to P. aeruginosa infection in patients with cystic fibrosis","volume":"13","author":"De R","year":"2005","journal-title":"Eur J Hum Genet"},{"key":"R30-10-20210206","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1164\/rccm.200508-1281OC","article-title":"Variants in the glutamate-cysteine-ligase gene are associated with cystic fibrosis lung disease","volume":"174","author":"McKone","year":"2006","journal-title":"Am J Respir Crit Care Med"},{"key":"R31-10-20210206","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1007\/BF02267078","article-title":"Proportion of the GSTM1 0\/0 genotype in some Slavic populations and its correlation with cystic fibrosis and some multifactorial diseases","volume":"97","author":"Baranov","year":"1996","journal-title":"Hum Genet"},{"key":"R32-10-20210206","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1136\/thx.53.12.1018","article-title":"Contribution of genetic factors other than CFTR to disease severity in cystic fibrosis","volume":"53","author":"Hull","year":"1998","journal-title":"Thorax"},{"key":"R33-10-20210206","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1053\/jhep.2002.35534","article-title":"Liver disease in pediatric patients with cystic fibrosis is associated with glutathione S-transferase P1 polymorphism","volume":"36","author":"Henrion-Caude","year":"2002","journal-title":"Hepatology"},{"key":"R34-10-20210206","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1097\/00008571-200405000-00004","article-title":"Glutathione-S-transferase M1, M3, P1 and T1 polymorphisms and severity of lung disease in children with cystic fibrosis","volume":"14","author":"Flamant","year":"2004","journal-title":"Pharmacogenetics"},{"key":"R35-10-20210206","first-page":"401","article-title":"Polymorphism of glutathione-S-transferase M1 and P1 genes in patients with cystic fibrosis and chronic respiratory tract diseases","volume":"40","author":"Korytina","year":"2004","journal-title":"Genetika"},{"key":"R36-10-20210206","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1089\/gte.1998.2.85","article-title":"Is the hemochromatosis gene a modifier locus for cystic fibrosis?","volume":"2","author":"Rohlfs","year":"1998","journal-title":"Genet Test"},{"key":"R37-10-20210206","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1089\/109065703322146876","article-title":"HFE alleles in an Irish cystic fibrosis population","volume":"7","author":"Devaney","year":"2003","journal-title":"Genet Test"},{"key":"R38-10-20210206","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/0168-8278(95)80058-1","article-title":"The major histocompatibility complex influences the development of chronic liver disease in male children and young adults with cystic fibrosis","volume":"23","author":"Duthie","year":"1995","journal-title":"J Hepatol"},{"key":"R39-10-20210206","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1111\/j.1651-2227.1993.tb12628.x","article-title":"Diabetes mellitus in cystic fibrosis: genetic and immunological markers","volume":"82","author":"Lanng","year":"1993","journal-title":"Acta Paediatr"},{"key":"R40-10-20210206","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/BF01546319","article-title":"Cystic fibrosis-related diabetes is associated with HLA DQB1 alleles encoding Asp-57- molecules","volume":"14","author":"Carrington","year":"1994","journal-title":"J Clin Immunol"},{"key":"R41-10-20210206","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1164\/ajrccm.159.5.9807046","article-title":"HLA class II polymorphism in cystic fibrosis","volume":"159","author":"Aron","year":"1999","journal-title":"Am J Resp Crit Care Med"},{"key":"R42-10-20210206","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1086\/429964","article-title":"Influence of interleukin-10 on Aspergillus fumigatus infection in patients with cystic fibrosis","volume":"191","author":"Brouard","year":"2005","journal-title":"J Infect Dis"},{"key":"R43-10-20210206","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1136\/bmj.319.7218.1166","article-title":"Association of variant alleles of mannose binding lectin with severity of pulmonary disease in cystic fibrosis: cohort study","volume":"319","author":"Gabolde","year":"1999","journal-title":"Br Med J"},{"key":"R44-10-20210206","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1172\/JCI6861","article-title":"Association of mannose-binding lectin gene heterogeneity with severity of lung disease and survival in cystic fibrosis","volume":"104","author":"Garred","year":"1999","journal-title":"J Clin Invest"},{"key":"R45-10-20210206","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1136\/jmg.38.5.310","article-title":"The mannose binding lectin gene influences the severity of chronic liver disease in cystic fibrosis","volume":"38","author":"Gabolde","year":"2001","journal-title":"J Med Genet"},{"key":"R46-10-20210206","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1183\/09031936.04.00055404","article-title":"Impaired pulmonary status in cystic fibrosis adults with two mutated MBL-2 alleles","volume":"24","author":"Davies","year":"2004","journal-title":"Eur Respir J"},{"key":"R47-10-20210206","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/jmg.2003.017947","article-title":"Polymorphisms in the mannose binding lectin gene affect the cystic fibrosis pulmonary phenotype","volume":"41","author":"Yarden","year":"2004","journal-title":"J Med Genet"},{"key":"R48-10-20210206","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1111\/j.1365-2249.2004.02690.x","article-title":"Deficiency of the mannan-binding lectin pathway of complement and poor outcome in cystic fibrosis: bacterial colonization may be decisive for a relationship","volume":"139","author":"Carlsson","year":"2005","journal-title":"Clin Exp Immunol"},{"key":"R49-10-20210206","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.jcf.2005.04.001","article-title":"MBL2 polymorphisms screening in a regional Italian CF center","volume":"4","author":"Trevisiol","year":"2005","journal-title":"J Cyst Fibros"},{"key":"R50-10-20210206","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1002\/ppul.20361","article-title":"Association of common haplotypes of surfactant protein A1 and A2 (SFTPA1 and SFTPA2) genes with severity of lung disease in cystic fibrosis","volume":"41","author":"Choi","year":"2006","journal-title":"Pediatr Pulmonol"},{"key":"R51-10-20210206","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.clim.2006.08.014","article-title":"The mannan-binding lectin pathway and lung disease in cystic fibrosis \u2013 disfunction of mannan-binding lectin-associated serine protease 2 (MASP-2) may be a major modifier","volume":"121","author":"Olesen","year":"2006","journal-title":"Clin Immunol"},{"key":"R52-10-20210206","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1136\/jmg.2006.046318","article-title":"Variants in mannose-binding lectin and tumor necrosis factor {alpha} affect survival in cystic fibrosis","volume":"44","author":"Buranawuti","year":"2007","journal-title":"J Med Genet"},{"key":"R53-10-20210206","first-page":"1040","article-title":"Complex two-gene modulation of lung disease severity in children with cystic fibrosis","volume":"118","author":"Dorfman","year":"2008","journal-title":"J Clin Invest"},{"key":"R54-10-20210206","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1164\/rccm.200412-1714OC","article-title":"Cystic fibrosis, disease severity, and a macrophage migration inhibitory factor polymorphism","volume":"172","author":"Plant","year":"2005","journal-title":"Am J Respir Crit Care Med"},{"key":"R55-10-20210206","doi-asserted-by":"crossref","first-page":"2172","DOI":"10.1164\/ajrccm.162.6.2003106","article-title":"Airway nitric oxide levels in cystic fibrosis patients are related to a polymorphism in the neuronal nitric oxide synthase gene","volume":"162","author":"Grasemann","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"key":"R56-10-20210206","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1006\/niox.2001.0408","article-title":"Nasal nitric oxide levels in cystic fibrosis patients are associated with a neuronal NO synthase (NOS1) gene polymorphism","volume":"6","author":"Grasemann","year":"2002","journal-title":"Nitric Oxide"},{"key":"R57-10-20210206","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1136\/thorax.2003.006718","article-title":"Nitric oxide synthase 1 as a potential modifier gene of decline in lung function in patients with cystic fibrosis","volume":"59","author":"Texereau","year":"2004","journal-title":"Thorax"},{"key":"R58-10-20210206","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1164\/rccm.200202-155OC","article-title":"Endothelial nitric oxide synthase variants in cystic fibrosis lung disease","volume":"167","author":"Grasemann","year":"2003","journal-title":"Am J Respir Crit Care Med"},{"key":"R59-10-20210206","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/ppul.1950180104","article-title":"Allotypes of alpha 1-antitrypsin in patients with cystic fibrosis, homozygous and heterozygous for deltaF508","volume":"18","author":"Doring","year":"1994","journal-title":"Pediatr Pulmonol"},{"key":"R60-10-20210206","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1183\/09031936.98.11040873","article-title":"Alpha1-antitrypsin deficiency alleles and the Taq-I G\u2192A allele in cystic fibrosis lung disease","volume":"11","author":"Mahadeva","year":"1998","journal-title":"Eur Respir J"},{"key":"R61-10-20210206","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1136\/thx.53.12.1022","article-title":"Alpha-1 antitrypsin deficiency alleles and severe cystic fibrosis lung disease","volume":"53","author":"Mahadeva","year":"1998","journal-title":"Thorax"},{"key":"R62-10-20210206","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1038\/sj.ejhg.5200623","article-title":"An alpha(1)-antitrypsin enhancer polymorphism is a genetic modifier of pulmonary outcome in cystic fibrosis","volume":"9","author":"Henry","year":"2001","journal-title":"Eur J Hum Genet"},{"key":"R63-10-20210206","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1034\/j.1399-0004.2002.620413.x","article-title":"Analysis of the two common alpha-1-antitrypsin deficiency alleles PiMS and PiMZ as modifiers of Pseudomonas aeruginosa susceptibility in cystic fibrosis","volume":"62","author":"Meyer","year":"2002","journal-title":"Clin Genet"},{"key":"R64-10-20210206","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1165\/rcmb.2002-0271OC","article-title":"Alpha 1-antitrypsin deficiency alleles in cystic fibrosis lung disease","volume":"29","author":"Frangolias","year":"2003","journal-title":"Am J Respir Cell Mol Biol"},{"key":"R65-10-20210206","doi-asserted-by":"crossref","first-page":"485","DOI":"10.2223\/JPED.1423","article-title":"Association between alpha 1 antitrypsin deficiency and cystic fibrosis severity","volume":"81","author":"de Faria","year":"2005","journal-title":"J Pediatr (Rio J)"},{"key":"R66-10-20210206","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1002\/ppul.20416","article-title":"Association of improved pulmonary phenotype in Irish cystic fibrosis patients with a 3\u2032 enhancer polymorphism in alpha-1-antitrypsin","volume":"41","author":"Courtney","year":"2006","journal-title":"Pediatr Pulmonol"},{"key":"R67-10-20210206","first-page":"381","article-title":"Genetic modifiers of severe liver disease in cystic fibrosis: a replication study","volume":"30","author":"Stonebraker","year":"2007","journal-title":"Pediatr Pulmonol Suppl"},{"key":"R68-10-20210206","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1136\/thorax.56.1.53","article-title":"Association of alpha(1)-antichymotrypsin deficiency with milder lung disease in patients with cystic fibrosis","volume":"56","author":"Mahadeva","year":"2001","journal-title":"Thorax"},{"key":"R69-10-20210206","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s00005-006-0029-8","article-title":"Modifier effect of the Toll-like receptor 4 D299G polymorphism in children with cystic fibrosis","volume":"54","author":"Urquhart","year":"2006","journal-title":"Arch Immunol Ther Exp (Warsz)"},{"key":"R70-10-20210206","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1136\/thorax.55.6.459","article-title":"TGF-beta(1) genotype and accelerated decline in lung function of patients with cystic fibrosis","volume":"55","author":"Arkwright","year":"2000","journal-title":"Thorax"},{"key":"R71-10-20210206","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.clim.2006.08.015","article-title":"Polymorphisms of TGF-beta1 in cystic fibrosis patients","volume":"121","author":"Brazova","year":"2006","journal-title":"Clin Immunol"},{"key":"R72-10-20210206","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1001\/jama.299.4.417","article-title":"Interactions between secondhand smoke and genes that affect cystic fibrosis lung disease","volume":"299","author":"Collaco","year":"2008","journal-title":"JAMA"},{"key":"R73-10-20210206","doi-asserted-by":"crossref","first-page":"2228","DOI":"10.1093\/hmg\/ddn123","article-title":"Interaction between a novel TGFB1 haplotype and CFTR genotype is associated with improved lung function in cystic fibrosis","volume":"17","author":"Bremer","year":"2008","journal-title":"Hum Mol Genet"},{"key":"R74-10-20210206","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1136\/thx.2004.025262","article-title":"Association of tumour necrosis factor alpha variants with the CF pulmonary phenotype","volume":"60","author":"Yarden","year":"2005","journal-title":"Thorax"},{"key":"R75-10-20210206","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1093\/intimm\/dxl091","article-title":"The 8.1 ancestral MHC haplotype is associated with delayed onset of colonization in cystic fibrosis","volume":"18","author":"Laki","year":"2006","journal-title":"Int Immunol"},{"key":"R76-10-20210206","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s00408-005-2568-x","article-title":"TNF-alpha promoter polymorphism in relation to TNF-alpha production and clinical status in cystic fibrosis 1","volume":"184","author":"Schmitt-Grohe","year":"2006","journal-title":"Lung"},{"key":"R77-10-20210206","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1097\/00007890-199810270-00009","article-title":"Genotypic variation in the transforming growth factor-beta1 gene: association with transforming growth factor-beta1 production, fibrotic lung disease, and graft fibrosis after lung transplantation","volume":"66","author":"Awad","year":"1998","journal-title":"Transplantation"},{"key":"R78-10-20210206","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1164\/rccm.200210-1165OC","article-title":"Transforming growth factor-beta1 gene polymorphisms are associated with disease progression in idiopathic pulmonary fibrosis","volume":"168","author":"Xaubet","year":"2003","journal-title":"Am J Respir Crit Care Med"},{"key":"R79-10-20210206","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/j.ajhg.2008.01.018","article-title":"On the replication of genetic associations: timing can be everything!","volume":"82","author":"Lasky-Su","year":"2008","journal-title":"Am J Hum Genet"},{"key":"R80-10-20210206","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1086\/379324","article-title":"Impact of mannose-binding lectin on susceptibility to infectious diseases","volume":"37","author":"Eisen","year":"2003","journal-title":"Clin Infect Dis"},{"key":"R81-10-20210206","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.humimm.2006.02.030","article-title":"Mannose-binding lectin: clinical implications for infection, transplantation, and autoimmunity","volume":"67","author":"Bouwman","year":"2006","journal-title":"Hum Immunol"},{"key":"R82-10-20210206","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1111\/j.1365-2249.2006.03151.x","article-title":"Association between mannan-binding lectin and impaired lung function in cystic fibrosis may be age-dependent","volume":"145","author":"Muhlebach","year":"2006","journal-title":"Clin Exp Immunol"},{"key":"R83-10-20210206","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1183\/09031936.00155607","article-title":"TNFA \u2212308G>A in two international population-based cohorts and risk for asthma","volume":"32","author":"Castro-Giner","year":"2008","journal-title":"Eur Respir J"},{"key":"R84-10-20210206","first-page":"588","article-title":"Association of tumor necrosis factor alpha 308 G\/A gene promoter polymorphism with the presence of chronic obstructive pulmonary disease: a meta-analysis","volume":"30","author":"Hu","year":"2007","journal-title":"Zhonghua Jie He He Hu Xi Za Zhi"},{"key":"R85-10-20210206","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1136\/adc.68.3.389","article-title":"Sputum tumour necrosis factor-alpha and leukotriene concentrations in cystic fibrosis","volume":"68","author":"Greally","year":"1993","journal-title":"Arch Dis Child"},{"key":"R86-10-20210206","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.jcf.2005.09.011","article-title":"Calpain 10 and development of diabetes mellitus in cystic fibrosis","volume":"5","author":"Derbel","year":"2006","journal-title":"J Cyst Fibros"},{"key":"R87-10-20210206","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1016\/j.rmed.2008.01.009","article-title":"Alpha-1 antitrypsin null mutations and severity of emphysema","volume":"102","author":"Fregonese","year":"2008","journal-title":"Respir Med"},{"key":"R88-10-20210206","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1164\/rccm.2112065","article-title":"Effects of glutathione-S-transferase M1, T1, and P1 on childhood lung function growth","volume":"166","author":"Gilliland","year":"2002","journal-title":"Am J Respir Crit Care Med"},{"key":"R89-10-20210206","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1159\/000106316","article-title":"The GSTP1 gene is a susceptibility gene for childhood asthma and the GSTM1 gene is a modifier of the GSTP1 gene","volume":"144","author":"Kamada","year":"2007","journal-title":"Int Arch Allergy Immunol"},{"key":"R90-10-20210206","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1289\/ehp.10655","article-title":"Glutathione S-transferase P1, maternal smoking, and asthma in children: a haplotype-based analysis","volume":"116","author":"Li","year":"2008","journal-title":"Environ Health Perspect"},{"key":"R91-10-20210206","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1136\/thx.2007.085555","article-title":"Glutathione S-transferase genotype increases risk of progression from bronchial hyperresponsiveness to asthma in adults","volume":"63","author":"Imboden","year":"2008","journal-title":"Thorax"},{"key":"R92-10-20210206","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/978-1-59745-205-2_11","article-title":"Pharmacogenetics of asthma","volume":"448","author":"Hawkins","year":"2008","journal-title":"Methods Mol Biol"},{"key":"R93-10-20210206","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1164\/rccm.200306-779OC","article-title":"Effect of ambient air pollution on pulmonary exacerbations and lung function in cystic fibrosis","volume":"169","author":"Goss","year":"2004","journal-title":"Am J Respir Crit Care Med"},{"key":"R94-10-20210206","doi-asserted-by":"crossref","first-page":"497","DOI":"10.18553\/jmcp.2007.13.6.497","article-title":"Implications of pharmacogenomics in the current and future treatment of asthma","volume":"13","author":"Morrow","year":"2007","journal-title":"J Manag Care Pharm"}],"container-title":["Current Opinion in Pulmonary Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MCP.0b013e3283121cdc","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T01:22:57Z","timestamp":1738372977000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00063198-200811000-00010"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,11]]},"references-count":94,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2008]]}},"URL":"https:\/\/doi.org\/10.1097\/mcp.0b013e3283121cdc","relation":{},"ISSN":["1070-5287"],"issn-type":[{"value":"1070-5287","type":"print"}],"subject":[],"published":{"date-parts":[[2008,11]]}}}